Eric M. Dube, Chief Executive Officer at Travere Therapeutics, Inc. (TVTX), sold 15,746 shares at $24.98 ($393K) on 2022-01-24, disclosed to the SEC on 2022-01-26.
Open-market sale of $393k TVTX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.98 | 7,873 | $197K | 50.0% |
| 2 | $24.98 | 7,873 | $197K | 50.0% |
| Total | $24.98 avg | 15,746 | $393K | 100% |
| Filing → |
| TVTX | SELL | 2026-04-15 | $2.6M | — | Filing → |
| TVTX | SELL | 2026-04-02 | $1.9M | — | Filing → |
| TVTX | SELL | 2026-02-24 | $1.8M | — | Filing → |